XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Cash Flows (USD $)
6 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Conversion of Preferred Stock and Accrued Dividends to Common Stock
Mar. 31, 2013
Conversion of Preferred Stock and Accrued Dividends to Common Stock
Mar. 31, 2014
Conversion of Redeemable Warrant Liability to Common Stock
Mar. 31, 2013
Conversion of Redeemable Warrant Liability to Common Stock
Cash flows from operating activities            
Net loss $ (5,939,473) $ (7,286,378)        
Adjustments to reconcile net loss to net cash used in operating activities            
Depreciation expense 59,444 78,500        
Stock-based compensation 218,236 201,607        
Non-cash interest expense 0 293,103        
Amortization of deferred financing costs 0 57,850        
Amortization of debt discount 0 654,528        
Change in fair value of warrant liability 573,582 0        
Changes in operating assets and liabilities            
(Increase) decrease in accounts receivable (2,696,274) 89,239        
Increase in inventories 0 (159,419)        
Decrease (increase) in prepaid expenses and other current assets 1,069,948 (951,405)        
Decrease in other assets 1,320 0        
Increase in accounts payable 1,265,654 2,557,229        
(Decrease) increase in deferred revenue (325,000) 1,742,500        
Increase (decrease) in accrued expenses and other liabilities 3,723,990 (108,332)        
Net cash used for operating activities (2,048,573) (2,830,978)        
Cash flows from investing activities            
Purchase of property and equipment (34,616) 0        
Proceeds from short term investments 0 1,500,000        
Net cash (used in) provided by investing activities (34,616) 1,500,000        
Cash flows from financing activities            
Proceeds from exercise of preferred stock warrants 20,868 0        
Proceeds from issuance of common stock from initial public offering, net of issuance costs 46,487,456 0        
Net cash provided by (used in) financing activities 46,507,145 (82,482)        
Net increase (decrease) in cash 44,423,956 (1,413,460)        
Cash and cash equivalents at beginning of period 10,455,565 5,066,886        
Cash and cash equivalents at end of period 54,879,521 3,653,426        
Supplemental disclosures of cash flow information            
Interest 1,432 0        
Financing costs 5,157,544 2,463        
Franchise taxes 9,295 2,085        
Conversion of note payable to preferred stock            
Fair value of warrants issued with notes payable and the beneficial conversion feature 0 1,309,054        
Conversion of note payable to preferred stock 0 10,062,296        
Conversion to Common Stock     91,647,889 15,623,157 2,280,443 0
Accrued initial public offering costs $ 414,026 $ 0